Cellectis SA (CLLS)

4.09 +0.13 (+3.28%) USD  |  NASDAQ  |  Feb 24, 11:43
More

Cellectis Accrued Expenses (Quarterly)

Accrued Expenses (Quarterly) Chart

View Accrued Expenses (Quarterly) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accrued Expenses (Quarterly) Range, Past 5 Years

View Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accrued Expenses (Quarterly) Benchmarks

View Accrued Expenses (Quarterly) Benchmarks
Start Trial
EDAP TMS SA --
DBV Technologies SA --
Ascendis Pharma A/S --
Akari Therapeutics Plc Upgrade
Biodexa Pharmaceuticals Plc Upgrade